Evidence map›Paper›PMID 26025072›Full record

ArticleBioorganic & medicinal chemistry2015

Influence of linker length in shape recognition of B* DNA by dimeric aminoglycosides.

Sunil Kumar, Meredith Newby Spano, Dev P Arya

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sunil KumarLaboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, SC 29634, United States.
Meredith Newby SpanoNUBAD, LLC, 900 B West Faris Road, Greenville, SC 29605, United States.
Dev P AryaLaboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, SC 29634, United States. Electronic address: dparya@clemson.edu.
Clemson University · USNubad (United States) · US

Funding

Development of Peptide Antibiotic Nucleic AcidsR41AI114114 · NIAID · NUBAD, LLC · PI ARYA, DEV PRIYA · 2014 to 2015
$595k
Development of Ets2-InhibitorsR15CA125724 · NCI · CLEMSON UNIVERSITY · PI ARYA, DEV PRIYA · 2008 to 2009
$398k
A novel assay for RNA targeted drugsR41GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2011 to 2011
$286k
NCI NIH HHS R15 CA125724NCI NIH HHS R15CA125724NIAID NIH HHS R41 AI114114NIAID NIH HHS R41AI114114NIGMS NIH HHS R41 GM097917
6 · The paper itself

Abstract

DNA-protein recognition has shown us the importance of DNA shapes in the recognition process. Specific high-affinity targeting of DNA shapes by small molecules is desirable for many biological applications that involve regulation of DNA based processes. Here, the effect of linker length and rigidity on the affinity of a conjugated neomycin dimer for a specific DNA shape (B* form) AT-rich DNA was explored. Binding constants approximating 10(8)M(-1) for optimal linker lengths of 18-19 atoms are reported herein.

Indexed as

AT Rich SequenceBinding SitesDimerizationDNA, B-FormKineticsNeomycinStructure-Activity RelationshipDNA, B-FormNeomycinAminoglycoside derivativesFluorescent intercalator displacementIsothermal calorimetry titrationMajor groove bindersNucleic acid

Identifiers

PMID26025072
PMCPMC4837466
OpenAlexW605061830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.